OraSure (OSUR) Receives Approval to Label OraQuick Rapid HCV Antibody Test with CE Mark

December 15, 2009 6:53 AM EST Send to a Friend
OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it has received approval to affix the CE mark to its OraQuick ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login